Dwarfism
|
0.110 |
GeneticVariation
|
disease |
BEFREE |
Mutations in PIK3C2A cause syndromic short stature, skeletal abnormalities, and cataracts associated with ciliary dysfunction.
|
31034465 |
2019 |
Schizophrenia
|
0.110 |
GeneticVariation
|
disease |
BEFREE |
Likewise, PIK3C2A identified in the gene-based analysis is located in a combined bipolar and schizophrenia GWAS locus.
|
28195573 |
2017 |
Schizophrenia
|
0.110 |
GeneticVariation
|
disease |
GWASCAT |
Polygenic dissection of diagnosis and clinical dimensions of bipolar disorder and schizophrenia.
|
24280982 |
2014 |
Schizophrenia
|
0.110 |
GeneticVariation
|
disease |
GWASCAT |
Genome-wide association study identifies five new schizophrenia loci.
|
21926974 |
2011 |
Schizophrenia
|
0.110 |
GeneticVariation
|
disease |
GWASDB |
Genome-wide association study identifies five new schizophrenia loci.
|
21926974 |
2011 |
Dwarfism
|
0.110 |
Biomarker
|
disease |
HPO |
|
|
|
Body Height
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |
Alcohol consumption
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Novel genetic associations for blood pressure identified via gene-alcohol interaction in up to 570K individuals across multiple ancestries.
|
29912962 |
2018 |
Systolic Pressure
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Novel genetic associations for blood pressure identified via gene-alcohol interaction in up to 570K individuals across multiple ancestries.
|
29912962 |
2018 |
HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Genome-wide association study of virologic response with efavirenz-containing or abacavir-containing regimens in AIDS clinical trials group protocols.
|
25461247 |
2015 |
HIV-1, RESISTANCE TO
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Genome-wide association study of virologic response with efavirenz-containing or abacavir-containing regimens in AIDS clinical trials group protocols.
|
25461247 |
2015 |
ACQUIRED IMMUNODEFICIENCY SYNDROME, PROGRESSION TO
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Genome-wide association study of virologic response with efavirenz-containing or abacavir-containing regimens in AIDS clinical trials group protocols.
|
25461247 |
2015 |
AIDS, PROGRESSION TO
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Genome-wide association study of virologic response with efavirenz-containing or abacavir-containing regimens in AIDS clinical trials group protocols.
|
25461247 |
2015 |
HIV-1 infection
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Genome-wide association study of virologic response with efavirenz-containing or abacavir-containing regimens in AIDS clinical trials group protocols.
|
25461247 |
2015 |
Mental disorders
|
0.100 |
GeneticVariation
|
group |
GWASDB |
Polygenic dissection of diagnosis and clinical dimensions of bipolar disorder and schizophrenia.
|
24280982 |
2014 |
Bipolar Disorder
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Polygenic dissection of diagnosis and clinical dimensions of bipolar disorder and schizophrenia.
|
24280982 |
2014 |
Psychotic Disorders
|
0.100 |
GeneticVariation
|
group |
GWASDB |
Polygenic dissection of diagnosis and clinical dimensions of bipolar disorder and schizophrenia.
|
24280982 |
2014 |
Cryptorchidism
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Glaucoma
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Hepatomegaly
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Hypercalcemia
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Hypercalciuria
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Hypocalcemia
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Hypodontia
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Hypothyroidism
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|